Detalhe da pesquisa
1.
Practical recommendations for using ctDNA in clinical decision making.
Nature
; 619(7969): 259-268, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438589
2.
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.
Cancer
; 130(10): 1758-1765, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422026
3.
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Gynecol Oncol
; 182: 63-69, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262240
4.
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Breast Cancer Res Treat
; 198(2): 383-390, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689092
5.
Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.
Cancer
; 128 Suppl 4: 861-874, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133659
6.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Breast Cancer Res Treat
; 196(1): 229-237, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045271
7.
Transforming the landscape of early cancer detection using blood tests-Commentary on current methodologies and future prospects.
Br J Cancer
; 124(9): 1475-1477, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558712
8.
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
Breast Cancer Res Treat
; 185(3): 557-566, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389409
9.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120223
10.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res
; 22(1): 22, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32070401
11.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977
12.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32378051
13.
Circulating Tumor DNA and Hepatocellular Carcinoma.
Semin Liver Dis
; 39(4): 452-462, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226727
14.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
15.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
16.
Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas.
Clin Gastroenterol Hepatol
; 16(10): 1632-1640.e1, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29526691
17.
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
Breast Cancer Res Treat
; 168(3): 639-647, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289986
18.
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
Breast Cancer Res Treat
; 167(1): 89-99, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913760
19.
Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.
Clin Chem
; 64(12): 1732-1742, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237149
20.
Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.
Cancer Metastasis Rev
; 35(2): 323-32, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27023712